28868-d96963d2a43e819eea8abf9e5f1eb22a-medium_jpg

Sanguine

Accelerating Personalized Medicine R&D via Social and Big Data; Biological/Clinical Data

Product

  • Sanguine is a technology-enabled company innovating at the intersection of personalized medicine, biobanking, and biomedical research. It has a simple and attractive, proven business model. Sanguine collects blood samples and associated medical data from patients diagnosed with specific conditions. It processes those samples to extract biospecimen such as cells, serum, plasma and DNA, and stores them along with the medical data. It then sells the biospecimen and data to academic and pharmaceutical entities for research purposes.
  • Problem & Solution:

Product

  • Traditionally, research companies need to wait for physicians to set up appointments with patients and to find some willing to sign up. Patients go to Sanguine because Sanguine offers increased transparency in the research process, showing them where samples are used and how they advance biomedical research in areas they care about.

Product

Product

344909-14bef46c47a343437247d7cfba6d1aa650867cbf

Product

344910-8dd7c45df2805e665fffe96781708c603553ca59

Product

344911-de46e85b5acad6aec5cb0e504e74a73fcb61620c

Tech

  • Sanguine has developed a mobile app (Sangre) that efficiently deploys per diem nurses to perform blood donations at patients' homes that are interested in donating blood to Sanguine and to biomedical research.
  • Demo can be found at: http://vimeo.com/93113530

Founders

Founders

Founders

Founders

Founders

Founders

Founders

121344-medium_jpg?1405494571
Co-Founder, COO @Sanguine. UCLA Psychobiology. UCLA Anderson MBA. Clinical Research/Pharma Executive, Investment Consulting @Wilshire Associates, Inc.

Traction

Launched
  • November 2011
Blood Draws
  • 125 June 2014
Bookings
  • 230,000 June 2014
Employees
  • 19 June 2014

Traction

Enterprise Customers
  • 15 June 2014
Purchase Orders
  • 230,000 per mon June 2014
Total Users
  • 3,000 June 2014

Traction

Customers
  • Sanguine is growing its Purchase Orders volume by 75% Quarter over Quarter. We are currently working with 15 of the top 40 pharmaceutical companies (by market cap), and we are adding additional business development executives each month. The way to scale our business is to execute contracts (as opposed to Purchase Orders) with each of the pharma, and we are on our way to executing that arrangement.

Traction

Distribution
  • We have four sales executives across the country:
  • -New England
  • -Mid-Atlantic
  • -Pacific/Northwest
  • -Mid-West

Past Financing

Feb 2013
$2,000,000
-

Fundraising

Raising as equity
$4,000,000
Pre-Money Valuation
$15,500,000
Previously Raised
$6,000,000

Fundraising

Jobs

Jobs